Epidemiology and risk factors for healthcare-associated infections caused by Pseudomonas aeruginosa

Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis

(2020) Alfredo Ponce de Leon et al.   BMC INFECTIOUS DISEASES

Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: A systematic literature review and meta-analysis

(2018) Sanjay Merchant et al.   Journal of Global Antimicrobial Resistance

A systematic review on the use of time series data in the study of antimicrobial consumption and Pseudomonas aeruginosa resistance

(2018) Christos I. Athanasiou et al.   Journal of Global Antimicrobial Resistance

Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

(2018) Gowri Raman et al.   Antimicrobial Resistance and Infection Control

Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins, on antibiotic consumption and resistance of P.aeruginosa in an ICU

(2018) Salam Abbara et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art

(2017) Alberto Enrico Maraolo et al.   Expert Review of Anti-Infective Therapy

Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes

(2016) Anthony D. Harris et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis

(2015) Gowri Raman et al.   BMC INFECTIOUS DISEASES

Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis

(2015) Qianqian Liu et al.   Scientific Reports

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

(2014) Víctor Daniel Rosenthal et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care–associated infection control in the hospitals of Southern China: A case-control surveillance study

(2014) Yang Peng et al.   AMERICAN JOURNAL OF INFECTION CONTROL

A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa

(2014) A. F. Voor in 't holt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study

(2014) A.-G. Venier et al.   JOURNAL OF HOSPITAL INFECTION

Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome

(2014) Raquel Cavalcanti Dantas et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy

(2010) Mickaël Riou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa

(2009) A. L. Pakyz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY